We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Baidu
BIDU
$35.8B
| $18.2M | 0.03% |
137,568
+55,359
| +67% | +$8.35M |
|
527
Xylem
XYL
$28.5B
| $18.2M | 0.03% |
213,121
-66,863
| -24% | -$6.41M |
|
|
PV
528
DELISTED
Primavera Capital Acquisition Corporation
PV
| $18.2M | 0.03% |
1,848,023
| – | – |
|
529
California Resources
CRC
$4.75B
| $18.1M | 0.03% |
404,140
+65,250
| +19% | +$2.81M |
|
530
Canadian Pacific Kansas City
CP
$82B
| $18M | 0.03% |
218,330
-1,900,263
| -90% | -$143M |
|
|
PXD
531
DELISTED
Pioneer Natural Resource Co.
PXD
| $17.9M | 0.03% |
71,739
-622,445
| -90% | -$141M |
|
|
NSTB
532
DELISTED
Northern Star Investment Corp. II
NSTB
| $17.9M | 0.03% |
1,830,601
| – | – |
|
533
Illumina
ILMN
$29.4B
| $17.9M | 0.03% |
52,532
-136,259
| -72% | -$46M |
|
|
FITB
534
Fifth Third Bancorp
FITB
$52B
| $17.8M | 0.03% |
414,671
+401,906
| +3,148% | +$18.8M |
|
535
iShares Silver Trust
SLV
$28.1B
| $17.8M | 0.03% |
777,830
+574,955
| +283% | +$12.8M |
|
|
TETC
536
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
| $17.8M | 0.03% |
1,820,517
| – | – |
|
|
LHC
537
DELISTED
Leo Holdings Corp. II
LHC
| $17.8M | 0.03% |
1,813,861
| – | – |
|
538
Trupanion
TRUP
$1.05B
| $17.7M | 0.03% |
+198,966
| New | +$18.3M |
|
|
HMCO
539
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
| $17.7M | 0.03% |
1,806,980
| – | – |
|
540
Maravai LifeSciences
MRVI
$997M
| $17.7M | 0.03% |
501,212
+106,404
| +27% | +$3.57M |
|
541
BioCryst Pharmaceuticals
BCRX
$2.37B
| $17.7M | 0.03% |
+1,085,846
| New | +$17.4M |
|
542
Chevron
CVX
$388B
| $17.6M | 0.03% |
108,307
-143,569
| -57% | -$20.6M |
|
|
BTWN
543
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
| $17.5M | 0.03% |
1,779,027
| – | – |
|
544
Weibo
WB
$1.9B
| $17.4M | 0.03% |
709,186
-317,267
| -31% | -$9.37M |
|
|
PCPC
545
DELISTED
Periphas Capital Partnering Corporation
PCPC
| $17.3M | 0.03% |
706,391
+675,021
| +2,152% | +$16.5M |
|
546
CBRE Group
CBRE
$40.8B
| $17.3M | 0.03% |
188,594
-126,823
| -40% | -$12.4M |
|
547
Paylocity
PCTY
$6.71B
| $17.2M | 0.03% |
83,783
-49,425
| -37% | -$10M |
|
548
Asbury Automotive
ABG
$4.19B
| $17.2M | 0.03% |
107,217
-87,302
| -45% | -$15.3M |
|
549
Global Payments
GPN
$22.1B
| $17.1M | 0.03% |
125,194
-306,090
| -71% | -$42.8M |
|
550
Franklin Resources
BEN
$16.9B
| $17.1M | 0.03% |
612,971
-1,308,084
| -68% | -$40M |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.